Revenue Recognition - Schedule of Percentages by Source of Net Revenue (Details) - Revenue from Contract with Customer Benchmark - Customer Concentration Risk |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Concentration Risk [Line Items] | ||||
| Concentration risk percentage | 100.00% | 100.00% | 100.00% | 100.00% |
| Commercial insurers | ||||
| Concentration Risk [Line Items] | ||||
| Concentration risk percentage | 71.00% | 72.00% | 71.00% | 71.00% |
| Government payers | ||||
| Concentration Risk [Line Items] | ||||
| Concentration risk percentage | 15.00% | 16.00% | 14.00% | 15.00% |
| Patient | ||||
| Concentration Risk [Line Items] | ||||
| Concentration risk percentage | 14.00% | 12.00% | 15.00% | 14.00% |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|